In the Pakistani population, Hashmi and his colleagues have shown that EGFR under expression was linked to prostatic adenocarcinoma, suggesting it as clinical biomarker in cases with higher Gleason score, high grade and perineural association with prostate carcinoma [43]. The gene discussed is EGFR; the disease is prostate carcinoma.